Expression of ABC-1 transporter is elevated in human glioma cells under irradiation and temozolomide treatment

Amino Acids

Volumn 28, Issue 2, 2005, Pages 213-219

  Trog, D ^a   Moenkemann, H ^a   Haertel, N ^a   Schuller H ^a   Golubnitschaja, O ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

ABC 1; Differential gene expression; Glioma; Irradiation; Multidrug resistance; Temozolomide treatment

Indexed keywords

ABC TRANSPORTER A1; TEMOZOLOMIDE;

CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL COUNT; CELL CULTURE; CELL DENSITY; CELL LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; CROSS RESISTANCE; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; IRRADIATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RADIATION EXPOSURE; RADIATION RESPONSE; UPREGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, ALKYLATING; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; DACARBAZINE; GAMMA RAYS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; UP-REGULATION;

EID: 17044393992     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-005-0171-3     Document Type: Conference Paper

References (29)

1. Becq F, Hamon Y, Bajetto A, Gola M, Verrier B, Chimini G (1997) ABC1, an ATP binding cassette transporter required for phagocytosis of apoptotic cells, generates a regulated anion flux after expression in Xenopus laevis oocytes. J Biol Chem 272: 2695-2699
2. Bera TK, lavarone C, Kumar V, Lee S, Lee B, Pastan I (2002) MRP9, an unusual truncated member of the ABC transporter superfamily, is highly expressed in breast cancer. Proc Natl Acad Sci 99: 6997-7002
3. Bisoendial RJ, Hovingh GK, Levels JH, Lerch PG, Andresen I, Hayden MR, Kastelein JJ, Stroes ES (2003) Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein. Circulation 107: 2944-2948
4. Bower M, Newlands ES, Bleehen NM, Brada M, Begent RJ, Calvert H, Colquhoun I, Lewis P, Brampton MH (1997) Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol 40: 484-488
5. Chou PM, Reyes-Mugica M, Barquin N, Yasuda T, Tan X, Tomita T (1995) Multidrug resistance gene expression in childhood medulloblastoma: correlation with clinical outcome and DNA ploidy in 29 patients. Pediatr Neurosurg 23: 283-292
6. Denecke J, Fiedler K, Hacker-Klom U, Molenkamp G, Jurgens H, Wolff JE (1997) Multiple drug-resistant C6 glioma cells cross-resistant to irradiation. Anticancer Res 17: 4531-4534
7. Denny BJ, Wheelhouse RT, Stevens MF, Tsang LL, Slack JA (1994) NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA. Biochemistry 33: 9045-9051
8. Eisenblatter T, Galla HJ (2002) A new multidrug resistance protein at the blood-brain barrier. Biochem Biophys Res Commun 293: 1273-1278
9. Gottesman MM, Ambudkar SV (2001) Overview: ABC transporters and human disease. J Bioenerg Biomembr 33: 453-458
10. Hirose Y, Berger MS, Pieper RO (2001) Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells. Cancer Res 61: 5843-5849
11. Hirrlinger J, Konig J, Dringen R (2002) Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones. J Neurochem 82: 716-719
12. Horiguchi H, Sano T, Hirose T (2001) TP53 deleted cells in de novo glioblastomas using fluorescence in situ hybridization. Pathol Int 51: 187-192
13. Kohno K (1997) Molecular mechanism of the stress induction of MDR1 gene. Nippon Rinsho 55: 1054-1058
14. Kono K, Takahashi JA, Ueba T, Mori H, Hashimoto N, Fukumoto M (2002) Effects of combination chemotherapy with biscoclaurine-derived alkaloid (Cepharanthine) and nimustine hydrochloride on malignant glioma cell lines. J Neurooncol 56: 101-108
15. Lee G, Dallas S, Hong M, Bendayan R (2001) Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. Pharmacol Rev 53: 569-596
16. Luciani MF, Denizot F, Savary S, Mattei MG, Chimini G (1994) Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics 21: 150-159
17. Mengerink KJ, Vacquier VD (2002) An ATP-binding cassette transporter is a major glycoprotein of sea urchin sperm membranes. J Biol Chem 277: 40729-40734
18. Muller M (2000) Transcriptional control of hepatocanalicular transporter gene expression. Semin Liver Dis 20: 323-337
19. Nutt CL, Noble M, Chambers AF, Cairncross JG (2000) Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Res 60: 4812-4818
20. Osoba D, Brada M, Yung WK, Prados M (2000) Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme. J Clin Oncol 18: 1481-1491
21. Paulsen F, Hoffmann W, Becker G, Belka C, Weinmann M, Classen J, Kortmann RD, Bamberg M (1999) Chemotherapy in the treatment of recurrent glioblastoma multiforme: ifosfamide versus temozolomide. J Cancer Res Clin Oncol 125: 411-418
22. Prayson RA, Mohan DS, Song P, Suh JH (2000) Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas. Ann Diagn Pathol 4: 218-227
23. Rahmati S, Yang S, Davidson AL, Zechiedrich EL (2002) Control of the AcrAB multidrug efflux pump by quorum-sensing regulator SdiA. Mol Microbiol 43: 677-685
24. Rust S, Walter M, Funke H, von Eckardstein A, Cullen P, Kroes HY, Hordijk R, Geisel J, Kastelein J, Molhuizen HO, Schreiner M, Mischke A, Hahmann HW, Assmann G (1998) Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy. Nat Genet 20: 96-98
25. Spiegl-Kreinecker S, Buchroithner J, Elbling L, Steiner E, Wurm G, Bodenteich A, Fischer J, Micksche M, Berger W (2002) Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes. J Neurooncol 57: 27-36
26. Wedge SR, Porteous JK, Newlands ES (1996) 3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity. Br J Cancer 74: 1030-1036
27. Yamaguchi M, Kita K, Miwa H, Nishii K, Oka K, Ohno T, Shirakawa S, Fukumoto M (1995) Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer 76: 2351-2356
28. Yung WK, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS, Albright R, Olson J, Chang SM, O'Neill AM, Friedman AH, Bruner J, Yue N, Dugan M, Zaknoen S, Levin VA (1999) Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 17: 2762-2771
29. Zhou R, Vitols S, Gruber A, Liliemark J, Wang Y, Liliemark E (1999) Etoposide-induced DNA strand breaks in relation to p-glycoprotein and topoisomerase II protein expression in leukaemic cells from patients with AML and CLL. Br J Haematol 105: 420-427